Urologix Com (NASDAQ:ULGX)

CAPS Rating: No stars

The Company develops, manufactures and markets non-surgical, catheter-based therapies that use a proprietary cooled microwave technology for the treatment of benign prostatic hyperplasia.

No players have picked ULGX yet. Tell us why you think ULGX will outperform or underperform the market.

Featured Broker Partners